FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.0212 $0.0381 Friday, 31st May 2024 CMRA stock ended at $0.0227. During the day the stock fluctuated 35.24% from a day low at $0.0227 to a day high of $0.0307.
90 days $0.0212 $0.0599
52 weeks $0.0212 $0.720

Historical Comera Life Sciences Holdings, Inc. prices

Date Open High Low Close Volume
Jun 03, 2022 $2.41 $2.41 $1.96 $2.00 137 496
Jun 02, 2022 $2.30 $2.46 $2.25 $2.35 110 744
Jun 01, 2022 $2.30 $2.43 $2.20 $2.31 111 660
May 31, 2022 $2.49 $2.87 $2.19 $2.19 387 724
May 27, 2022 $2.50 $3.08 $2.50 $2.50 838 280
May 26, 2022 $5.30 $5.79 $3.32 $3.39 711 231
May 25, 2022 $6.90 $7.18 $5.26 $5.35 352 123
May 24, 2022 $7.87 $7.98 $6.56 $7.23 268 006
May 23, 2022 $9.12 $9.81 $7.71 $8.00 899 389
May 20, 2022 $9.75 $11.44 $8.80 $8.85 250 619

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use CMRA stock historical prices to predict future price movements?
Trend Analysis: Examine the CMRA stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the CMRA stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings. Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis dis... CMRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT